Friday, November 8, 2024

First results of Russian Covid vaccine trial to include data from 5,000-10,000 people: Developers

Must Read

Share

Loading

Interim results from Russia’s late-stage human trial of a Covid-19 vaccine could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.

The trial of the Sputnik V vaccine, involving 40,000 volunteers, has been under way in Moscow since the beginning of September. Interim results are expected to be published in November.First results of Russian Covid vaccine trial to include data from 5,000-10,000 people: Developers

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Sensex, Nifty gain slightly in volatile trade; RVNL falls 5% after Q2 results

Benchmark stock market indices gained after opening lower in early trade as weak earnings in the second quarter and...

More Articles Like This